Free Trial
NYSE:NUS

Nu Skin Enterprises (NUS) Stock Price, News & Analysis

Nu Skin Enterprises logo
$7.23 +0.01 (+0.14%)
(As of 11/12/2024 ET)

About Nu Skin Enterprises Stock (NYSE:NUS)

Key Stats

Today's Range
$6.81
$7.33
50-Day Range
$6.07
$8.64
52-Week Range
$5.95
$20.75
Volume
947,124 shs
Average Volume
847,356 shs
Market Capitalization
$359.35 million
P/E Ratio
N/A
Dividend Yield
3.32%
Price Target
$8.88
Consensus Rating
Hold

Company Overview

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Nu Skin Enterprises Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
71st Percentile Overall Score

NUS MarketRank™: 

Nu Skin Enterprises scored higher than 71% of companies evaluated by MarketBeat, and ranked 63rd out of 145 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nu Skin Enterprises has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Nu Skin Enterprises has only been the subject of 1 research reports in the past 90 days.

  • Read more about Nu Skin Enterprises' stock forecast and price target.
  • Earnings Growth

    Earnings for Nu Skin Enterprises are expected to grow in the coming year, from ($2.27) to $1.05 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nu Skin Enterprises is -3.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nu Skin Enterprises is -3.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Nu Skin Enterprises has a P/B Ratio of 0.44. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Nu Skin Enterprises' valuation and earnings.
  • Percentage of Shares Shorted

    3.21% of the float of Nu Skin Enterprises has been sold short.
  • Short Interest Ratio / Days to Cover

    Nu Skin Enterprises has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nu Skin Enterprises has recently increased by 3.31%, indicating that investor sentiment is decreasing.
  • Dividend Leadership

    Nu Skin Enterprises is a leading dividend payer. It pays a dividend yield of 3.72%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Nu Skin Enterprises does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Nu Skin Enterprises will have a dividend payout ratio of 22.86% next year. This indicates that Nu Skin Enterprises will be able to sustain or increase its dividend.

  • Read more about Nu Skin Enterprises' dividend.
  • Percentage of Shares Shorted

    3.21% of the float of Nu Skin Enterprises has been sold short.
  • Short Interest Ratio / Days to Cover

    Nu Skin Enterprises has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nu Skin Enterprises has recently increased by 3.31%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Nu Skin Enterprises has a news sentiment score of -0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Consumer Staples companies.
  • News Coverage This Week

    MarketBeat has tracked 15 news articles for Nu Skin Enterprises this week, compared to 3 articles on an average week.
  • Search Interest

    10 people have searched for NUS on MarketBeat in the last 30 days. This is an increase of 233% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Nu Skin Enterprises to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nu Skin Enterprises insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.70% of the stock of Nu Skin Enterprises is held by insiders.

  • Percentage Held by Institutions

    82.84% of the stock of Nu Skin Enterprises is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Nu Skin Enterprises' insider trading history.
Receive NUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nu Skin Enterprises and its competitors with MarketBeat's FREE daily newsletter.

NUS Stock News Headlines

Nu Skin lays off more employees amid financial woes
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
See More Headlines

NUS Stock Analysis - Frequently Asked Questions

Nu Skin Enterprises' stock was trading at $19.42 on January 1st, 2024. Since then, NUS shares have decreased by 62.8% and is now trading at $7.23.
View the best growth stocks for 2024 here
.

Nu Skin Enterprises, Inc. (NYSE:NUS) announced its quarterly earnings results on Thursday, August, 8th. The company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.17 by $0.04. The company's revenue for the quarter was down 12.2% compared to the same quarter last year.

Nu Skin Enterprises' top institutional investors include Charles Schwab Investment Management Inc. (1.83%), Connor Clark & Lunn Investment Management Ltd. (0.55%), GSA Capital Partners LLP (0.19%) and Inspire Investing LLC (0.12%). Insiders that own company stock include Ryan S Napierski, Steven Keith Hatchett, Mark H Lawrence, Andrew D Lipman, Joseph Y Chang, Steven Lund, Edwina D Woodbury, James D Thomas, Laura Nathanson and Emma S Battle.
View institutional ownership trends
.

Shares of NUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nu Skin Enterprises investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Alphabet (GOOG) and Intel (INTC).

Company Calendar

Last Earnings
8/08/2024
Ex-Dividend for 9/11 Dividend
8/30/2024
Dividend Payable
9/11/2024
Today
11/12/2024
Ex-Dividend for 12/11 Dividend
11/29/2024
Dividend Payable
12/11/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
2/12/2025

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
Personal Products
CUSIP
67018T10
Employees
3,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.88
High Stock Price Target
$11.00
Low Stock Price Target
$6.75
Potential Upside/Downside
+22.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$8.60 million
Pretax Margin
-8.44%

Debt

Sales & Book Value

Annual Sales
$1.78 billion
Cash Flow
$3.63 per share
Book Value
$16.60 per share

Miscellaneous

Free Float
48,857,000
Market Cap
$359.35 million
Optionable
Optionable
Beta
1.14

Social Links

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (NYSE:NUS) was last updated on 11/13/2024 by MarketBeat.com Staff
From Our Partners